After being considered “off limits” for decades, the FDA has recently adopted a more open-minded stance towards psychedelic medicine. Not only does this new era for psychedelic medicine create an intriguing opportunity for investors, but “shroom stocks” may actually be a better investing opportunity than marijuana stocks. CLICK HERE.
